) Gastric cancer is the eleventh leading cause of cancer-related deaths in the United States and remains one of the most serious worldwide health burdens. Upper endoscopy is effective in the diagnosis of gastric cancer and surgery for localized disease is usually curative. The majority of gastric cancer patients, however, are diagnosed at a late stage of the disease and die soon after diagnosis. Studies have not identified subgroups of patients in whom screening to detect early gastric cancer may be effective. Further gastric cancer studies are needed to determine its environmental and genetic risk factors particularly using population-based patients and their families so that cancer prevention and control strategies can be developed. We propose to integrate techniques in genetic epidemiology and molecular biology to develop a means of identifying and characterizing inherited gastric cancer predisposing syndromes. The model will consider genetic factors that may be associated with tumor aggressiveness, environmental exposures and interactions among these factors. We will assemble a population-based series of approximately 350 gastric cancer cases and controls to assess the etiologic component associated with familial and potentially hereditary predisposition and to compare clinical, pathologic and prognostic features in sporadic, familial, and potentially hereditary gastric cancer. Methods already developed by the Epidemiology Division of UCI will be used to collect family history, epidemiologic risk factors, biologic samples (serum, lymphocytes, and paraffin-embedded tumor and normal tissue). We will test all gastric cancer cases for the replication error phenotype at microsatellites at seven loci. We will also test patient serum for IgG to Helicobacter pylori. Gene testing will be done on potential hereditary cases, focusing on the p53 and mismatch repair gene loci. This case-control study of possible genetic mutations will allow identification of populations at high risk for this cancer where opportunities for prevention and early detection of gastric cancer can be realized.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Academic/Teacher Award (ATA) (K07)
Project #
1K07CA074974-01A2
Application #
2751372
Study Section
Subcommittee G - Education (NCI)
Program Officer
Agelli, Maria
Project Start
1998-09-30
Project End
2003-09-29
Budget Start
1998-09-30
Budget End
1999-09-29
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of California Irvine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Irvine
State
CA
Country
United States
Zip Code
92697
Theuer, Charles P; Taylor, Thomas H; Brewster, Wendy R et al. (2006) Gender and race/ethnicity affect the cost-effectiveness of colorectal cancer screening. J Natl Med Assoc 98:51-7
Theuer, Charles P; Al-Kuran, Rasha; Akiyama, Yoshiyuki et al. (2006) Increased epithelial cadherin expression among Japanese intestinal-type gastric cancers compared with specimens from American patients of European descent. Am Surg 72:332-8
Theuer, Charles P; Campbell, Brian S; Peel, David J et al. (2002) Microsatellite instability in Japanese vs European American patients with gastric cancer. Arch Surg 137:960-5; discussion 965-6
Carpenter, Philip M; Al-Kuran, Rasha A; Theuer, Charles P (2002) Paranuaclear E-cadherin in gastric adenocarcinoma. Am J Clin Pathol 118:887-94
Theuer, C P; Taylor, T H; Brewster, W R et al. (2001) The topography of colorectal cancer varies by race/ethnicity and affects the utility of flexible sigmoidoscopy. Am Surg 67:1157-61
Theuer, C P; Wagner, J L; Taylor, T H et al. (2001) Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology 120:848-56
Theuer, C P; Kurosaki, T; Ziogas, A et al. (2000) Asian patients with gastric carcinoma in the United States exhibit unique clinical features and superior overall and cancer specific survival rates. Cancer 89:1883-92